Long Non-coding RNA MALAT1 Promotes Angiogenesis and Immunosuppressive Properties of HCC Cells by sponging miR-140.
Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer in adults. Previous studies in our lab found that long non-coding RNA (lncRNAs) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) was up regulated in HCC cells, which could affect the metastasis and invasion of HCC. However, the detailed mechanism remains unknown. Here, we studied the interaction between MALAT1 and miR-140 on the regulation of angiogenesis and immunosuppressive properties of HCC cells. Quantitative real-time PCR was employed to assess the expression of MALAT1, miR-140, IL-6, IL-10 and VEGF-A. Flow cytometry was used to measure the polarization of macrophage. Western blot was used to assess the expressions of VEGF-A. Dual-luciferase reporter assay was performed to verify the interaction between MALAT1 and miR-140 or miR-140 and VEGF-A. Tube formation assay was performed to determine the angiogenetic ability of Human Umbilical Vein Endothelial Cells (HUVECs). Transwell assay was used to assess the migration of HUVECs. Knockdown of MALAT1 in HCC cells could suppress the production of VEGF-A, impair the angiogenesis of HUVECs and facilitate the polarization of macrophage towards M1 subset. Mechanistically, the interaction between MALAT1 and miR-140 or between miR-140 and VEGF-A was confirmed by multiple assays. Furthermore, miR-140 inhibition significantly increased VEGF-A expression, promoted angiogenesis of HUVECs and re-directed the polarization of macrophage towards M2 subset. In summary, this study revealed the mechanisms by which MALAT1 worked as a putative HCC promotor via inhibiting miR-140. Therefore, targeting MALAT1 or miR-140 might alleviate the progression of HCC in future.